skip to main content

    Updated Visitor Guidelines

 

MENU

 

Brain Tumor

Glioma Research in Animal Models has Promising Results

A combination approach to treating a prevalent glioma subtype -- including metabolic reprogramming, radiation, chemotherapy and immunotherapy -- led to a complete regression of tumors in 60% of study mice.

Researchers Studying Whether an Anti-Rejection Drug Is Effective Against Glioblastoma

Research led by the Rogel Cancer Center is trying a new approach: Make radiation therapy more effective for glioblastoma patients by targeting a critical metabolic pathway and disrupting its ability to repair the DNA damage caused by the radiation.

Living with Brain Cancer

Andrea Passmore learned she had a brain tumor four days before her 51st birthday. Yet she has ultimately come to see the diagnosis as a kind of gift, an opportunity to share the outpouring of support that she has received during her cancer journey.

Glioblastoma Patient is Beating the Odds

Sixteen months ago, Kathy Bellmore was diagnosed with high-grade glioblastoma multiforme, an aggressive brain tumor with few good treatment options. Her tumor couldn't be operated on, so her doctors didn't think she would live beyond 6 months. She came to the U-M Rogel Cancer Center for a second opinion and is now beating the odds and continuing to make memories.

New Brain Cancer Research Could Improve Outcomes for those with Glioma

Researchers from the Rogel Cancer Center have found that a genetic mutation seen in about half of all brain tumors produces a response that prevents radiation treatment from working. Altering that response using FDA-approved drugs restores tumors’ sensitivity to radiation therapy, extending survival in mice.

Pages